You are comparing a Phase 3 to a phase 2 and talking about two completely different goals and patient population. I’m not even going to continue with this....
How many patients did SAVA have enrolled with their phase two. That’s right 25 and they are worth 1.5 billon and their results aren’t ground breaking. Its a phase 2 not a 3 so please spare me with the numbers.
IMO Biogen just got out on notice after these results.
News 
Market Data 
Discover 
